We performed a thorough systematic review of published literature to determine potential links between human health impacts and naled, a registered adult mosquito control product (adulticide), and its major degradate, dichlorvos (DDVP). A search query was performed on 8 September 2023, capturing all articles published up to that date on the Scopus and PubMed databases. Inclusion criteria were the presence of either pesticide and a measured or modeled human health outcome or risk. The search string resulted in 382 articles; however, 354 articles were excluded, resulting in only 28 articles that met the inclusion criteria. The studies that directly relate to aerosolized ultra-low volume (ULV) mosquito control applications did not report any associated deleterious human health outcomes. Results from the reviewed papers displayed no negative health effects or led to inconclusive results. No studies showed adverse health effects from aerial ULV applications for mosquito management. Our findings are congruent with the United States Environmental Protection Agency and Centers for Disease Control and Prevention recommendations that aerial applications of naled, following label parameters, do not pose an adverse risk exposure to humans, wildlife, and the environment.